ABSTRACT
To explore the effectiveness and safety of a Chinese medicinal decoction Wuwei Xiaodu Drink (WWXDD) in inhibiting chronic osteomyelitis via regulatory T cells signaling. The effective constitutes of WWXDD and osteomyelitis related genes were screened. Target proteins were cross-validated using the Venny database. GO function and KEGG pathway analysis were performed for target proteins, while pharmacological network was constructed. The bone properties were analyzed by HE staining and the concentrations of immune factors were measured by ELISA. The expression of CTLA-4 and Foxp3 mRNA and STAT5, p-STAT5, CTLA-4 and Foxp3 protein were detected using Real-time PCR and Western blot, respectively. FACS was used to analyze the percentages of cells. A total of 117 genes overlapped between 785 target genes of the active compounds of WWXDD and 912 osteomyelitis related genes. Inflammation-related genes, including IL-6, TNFα, IL-1β and IL-2 showed high connection degree in the drug-compound-disease-target network. GO function and KEGG pathway analysis revealed that 117 intersection genes mainly enriched in virus infection related pathways, immune related pathways and chemokine signaling pathway. Furthermore, the development of chronic osteomyelitis was suppressed in model rats after treatment with WWXDD. Meanwhile, the concentrations of IL-2 and CD4+CD25+Foxp3 Treg percentages together with the levels of p-STAT5, CTLA-4 and Foxp3 were also down-regulated. Furthermore, IL-2 and WWXDD drug-containing serum exhibited opposite effects on regulating IL-2, IL-10, TGF-β1, Foxp3, CTLA4 and STAT5. In addition, a STAT5 phosphorylation inhibitor suppressed the expression of Foxp3 and CTLA-4. WWXDD can treat chronic osteomyelitis through suppressing the main regulating factors of Tregs and interfere its immunodepression. Our results bring a new solution for chronic osteomyelitis.
Subject(s)
Animals , Rats , Forkhead Transcription Factors/metabolism , Interleukin-2/metabolism , Osteomyelitis/metabolism , STAT5 Transcription Factor/metabolism , Signal Transduction , T-Lymphocytes, RegulatoryABSTRACT
Objective. To study the nutritional status of children with Respiratory Syncitial virus infection. Methods. One hundred and twenty six children with acute respiratory infection, between the age of 4-24 months, were investigated for RSV infection with bronchiolitis, pneumonia and upper respiratory tract infection. Nasopharyngeal aspirates were collected and cytokine responses were determined by ELISA. Upper respiratory tract infections were detected in 16.66%, bronchiolitis in 30.15% and Pneumonia in 53.17% children. Results. Of the 126 patients, 46.66% children were positive for RSV while 58.33% were negative for RSV. Children with bronchiolitis were more commonly positive for RSV compared to URTI and pneumonia. RSV was almost equally distributed among boys (42.5%) and girls (48.7%). More children were RSV positive when the mean age lesser (8.4 mo) was compared to RSV negative (9.93 mo). Well nourished children and children with normal birth weight had more RSV positives, though not statistically significant. In a sub sample analysis of cytokines done (n=25), Interleukin-2 and Interleukin-8 levels were higher in the RSV positive children and these levels declined after 5 days of illness. Conclusions. RSV is more commonly associated with bronchiolitis in younger infants with normal birth weight or more weight for age (WFA). Proinflammatory cytokine IL-8 was secreted at high concentrations in the nasopharyngeal aspirate in all the children.
Subject(s)
Bronchiolitis, Viral/epidemiology , Bronchiolitis, Viral/immunology , Child, Preschool , Female , Humans , India/epidemiology , Infant , Interleukin-2/metabolism , Interleukin-8/metabolism , Male , Nutritional Status , Pneumonia, Viral/epidemiology , Pneumonia, Viral/immunology , Prevalence , Respiratory Syncytial Virus Infections/epidemiology , Respiratory Syncytial Virus Infections/immunology , Respiratory Tract Infections/epidemiology , Respiratory Tract Infections/immunology , Risk FactorsABSTRACT
Immunostimulatory activity of AC II, a registered ayurvedic preparation prepared at Amala Ayurvedic Research Centre for treating HIV and AIDS is reported. AC II administration could significantly enhance the mitogen-induced proliferation of lymphocytes of spleen cells. It was also found to increase cell-mediated immune responses in normal and tumor-bearing control animals. Oral administration of AC II significantly enhanced Natural Killer cell activity in normal and tumor-bearing animals on the 7th day, which was observed earlier than the tumor-bearing control animals and normal animals. Antibody dependent cellular cytotoxicity (ADCC) was also increased in AC II treated normal and tumor-bearing animals. An early enhancement of antibody-dependent complement-mediated cytotoxicity was also observed by the administration of AC II in normal as well as tumor-bearing animals. Treatment with AC II elevated the levels of IL-2, TNF-alpha and IFN-gamma in normal mice. Administration of AC II was also found to increase the cytotoxic T lymphocyte production in EL4 treated mice. These studies support the use of this immune stimulatory preparation in HIV patients.
Subject(s)
Animals , Anti-HIV Agents/therapeutic use , Cell Proliferation , HIV Infections/drug therapy , Humans , Interferon-gamma/metabolism , Interleukin-2/metabolism , K562 Cells , Killer Cells, Natural/cytology , MAP Kinase Signaling System , Medicine, Ayurvedic , Mice , Mice, Inbred BALB C , Spleen/metabolism , Tumor Necrosis Factor-alpha/metabolismABSTRACT
We performed this study to investigate the feature of rejection in porcine-to-rat corneal orthotopic transplantation and to evaluate the effect of cyclosporine and mycophenolate on the xeno-rejection. Orthotopic corneal transplantation was done at 91 Sprague-Dawley rats, and they were divided into 10 groups based on the combination of immunosuppressants including dexamethasone, cyclosporine, and mycophenolate mofetil. Graft survival was analyzed and grafted eyes were examined with Hematoxylin & Eosin and CD4 or CD8 staining. Enzyme-linked immunosorbent assays were done for interleukin-2 (IL-2), IL-4, IL-5, IL-10, and interferon (IFN)-gamma in cornea, lacrimal gland, and cervical lymph nodes. The longest median survival of the immune suppressant group was 11.00+/-1.96 days, which showed no statistical differences compared with that of control (8.00+/-1.52 days). The neutrophils were prominent in the early phase but soon gave way to the monocytes. The number of CD8+ cells was higher than that of CD4+ cells. IL-2 and IFN-gamma markedly increased at 10 to13 days in cornea, lacrimal glands, and cervical lymph nodes, which showed a decrease with immunosuppressants except in the cornea. In conclusion, cyclosporine and mycophenolate could not prevent the rejection in porcine to rat orthotopic corneal xenograft associated with infiltraton of CD8+ and innate immune cells.
Subject(s)
Animals , Rats , Corneal Transplantation , Cyclosporine/pharmacology , Cytokines/metabolism , Graft Rejection/immunology , Graft Survival/drug effects , Immunosuppressive Agents/pharmacology , Interferon-gamma/metabolism , Interleukin-10/metabolism , Interleukin-2/metabolism , Interleukin-4/metabolism , Interleukin-5/metabolism , Mycophenolic Acid/analogs & derivatives , Neutrophils/immunology , Rats, Sprague-Dawley , Swine , Transplantation, HeterologousABSTRACT
OBJECTIVE@#In order to explore the relationship between the expression change of cytokines and the wound age during the healing process of rats skin wound.@*METHODS@#A assay of ELISA were performed on intravital skin wounds(after incision 0.5-168 h) to detect the dynamics expression level of IL-2, TNF-alpha.@*RESULTS@#The level of IL-2 and TNF-alpha increased at 0.5 h after wounding, then got to a peak at 3 h and 1 h after injure respectively. Rebound of TNF and IL-2 levels were shown at 48 h after wounding, and both cytokine levels were inclined to elevating between 72 h and 168 h after wounding.@*CONCLUSION@#The cytokine level changes suggest they have a time-related expression during wounds healing process.
Subject(s)
Animals , Female , Male , Rats , Enzyme-Linked Immunosorbent Assay , Interleukin-2/metabolism , Rats, Wistar , Skin/metabolism , Time Factors , Tumor Necrosis Factor-alpha/metabolism , Wound Healing/physiologyABSTRACT
In a bid to characterize the antigens and immunization mechanisms which may be used to produce a protective response against L. donovani, role of lipid associated polysaccharide (LPS) antigen and whole antigen was evaluated. BALB/C mice were immunized with whole or LPS antigen in combination with one of three putative adjuvents (anti CD-2 antibody/FIA/0.85% Saline). LPS antigen emulsified in anti CD-2 antibody was found to induce significant antibodies in mice on day 28 against challenge with lethal dose of L. donovani. Immunoprophylactic properties of LPS and whole antigen was investigated on day 40 through cytokine elicitation (IL-2), MIF) in culture supernatants of spleen cells, but before that MHC-II expressed on macrophage was studied. The LPS antigen in combination with anti CD-2 antibody was found to be most immuno-reactive inducing higher MHC-II expression on macrophages which was associated with substantial rise in the level of MIF and IL-2. It coincided with decline in antibody titre in 100% mice immunized with LPS antigen while Leishmania injected as whole antigen failed to induce specific macrophage and T-cell response with all the above formulations. We surmise from our data that lipid associated polysaccharide antigen linked to anti CD-2 antibody has potential for eliciting protective immunity against Leishmania.
Subject(s)
Animals , Antibodies, Monoclonal/immunology , Antibodies, Protozoan/biosynthesis , CD2 Antigens/immunology , Antigens, Protozoan/immunology , Histocompatibility Antigens Class II/immunology , Immunity, Cellular/physiology , Immunization , Interleukin-2/metabolism , Leishmania donovani/immunology , Leishmaniasis, Visceral/immunology , Lipopolysaccharides/immunology , Macrophages/parasitology , Mice , Mice, Inbred BALB C , T-Lymphocytes/physiologyABSTRACT
Allergen activates T lymphocytes responsive to interleukin 2 (IL-2) in allergic patients but not in normal individuals. This response was suppressed by anti-allergic agent, Ketotifen (4-(1-methyl-4-piperidylidene)-4H-benzo [4, 5] cyclohepta [1, 2-b] thiophen-10 (9H)-one hydrogen (fumarate). Prolonged culture of antigen-presenting adherent cells impaired the ability to present Dermatophagoides farinae (Df) antigen to T cells, whereas stimulation of adherent cells with recombinant interferon-gamma (IFN-gamma) restored the antigen-presenting capability. The maintained antigen presenting ability of adherent cells treated with IFN-gamma was also suppressed by Ketotifen. Fluorescence activated cell sorter (FACS) analysis disclosed that Ketotifen selectively reduced the expression of HLA-DQ antigen, crucial restriction elements in Df antigen-related responses, on macrophages but not on B cells, even in the presence of IFN-gamma. Collectively, Ketotifen prevented macrophages from inducing allergen-activated T lymphocytes' responsiveness to IL-2 at least in part by decreasing the expression of HLA-DQ antigen.
Subject(s)
Adolescent , Adult , Anti-Allergic Agents/pharmacology , Antigen Presentation/drug effects , Asthma/immunology , Cell Adhesion/drug effects , Cells, Cultured , Child , Child, Preschool , Dose-Response Relationship, Drug , Flow Cytometry , HLA-DQ Antigens/metabolism , Humans , Interferon-gamma/metabolism , Interleukin-2/metabolism , Interleukin-4/metabolism , Ketotifen/pharmacology , Macrophages/drug effects , T-Lymphocytes/drug effectsABSTRACT
Treatment of Rhesus monkey peripheral blood lymphocytes and IL-2 dependent cell lines with heat prior to incubation with mitogens or IL-2, respectively, induces significant cell changes at the nuclear level, detected by DNA staining with Vindelov's propidium iodide and the simultaneous measurement of its red fluorescence and 90 degrees light scatter. These changes are an increase in their nuclear granularity and in apparently fragmented DNA which shows less fluorescence intensity than DNA from nuclei in the G0G1 phase, a phenomenon suggestive of apoptosis. Treated cells also show an increased number of nuclei in G1 or early S phase, with a reduction in those reaching the G2 or M phases. After heat-shock treatment, CTLL-2 cells show an increase in their response to low doses of recombinant IL-2 and an impaired ability to proliferate at higher IL-2 concentrations. These results provide further evidence for the regulatory role of stress-induced events
Subject(s)
Animals , Interleukin-2/metabolism , Lymphocytes/drug effects , Heat-Shock Proteins/pharmacology , Cell Cycle , Concanavalin A/pharmacology , Flow Cytometry , Hot Temperature , Lymphocytes/metabolism , Macaca mulatta , Cell Nucleus/drug effectsABSTRACT
Como todo factor de crecimiento, la interleucina-2 (IL-2) necesita unirse a un receptor específico, el IL-2 (IL-2R), para mediar su actividad. Este receptor se diferencia de los estudiados en endocrinología en que un factor no específico (IL-2) promueve una expansión clonal antígeno específica, sin inducir los IL-2R hasta que el receptor de antígenos es activado. El sistema se complica al descubrirse dos tipos de receptores para el IL-2, los de alta y baja afinidad. La explicación molecular, genética e importancia biológica del IL-2R se describe en el presente artículo, así como la trascendencia del empleo de las técnicas de anticuerpos monoclonales y de recombinación genética en la caracterización del IL-2R. Y teniendo como base dicha caracterización explicar algunos de los mecanismos que se proponen para la transducción de la señal y que culminan con la inducción de nuevos receptores para IL-2 y una proliferación ceclular